Global HP (High Potency) APIs Market Report 2024

HP (High Potency) APIs Global Market Report 2023 – By Type (Innovative HPAPI, Generic HPAPI), By Synthesis Type (Synthetic HPAPI, Biotech HPAPI), By Therapeutic Application (Oncology, Harmonal Disorder, Glaucoma, Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
HP (High Potency) APIs Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

High-potency APIs refer to the substances that, at very low doses, cause a biological response. Traditionally, cytotoxic substances and sex hormones like estrogen are used as examples of HPAPIs. Compared to standard APIs, highly potent active pharmaceutical ingredients HP (high potency) APIs market are nonetheless effective at considerably lower dosage levels, but their potency poses unique handling issues.

The main types of HP (high potency) APIs market are innovative HPAPI and generic HPAPI. The various types of synthesis include synthetic HPAPI and biotech HPAPI that are used for therapeutic applications such as oncology, hormonal disorders, glaucoma, and other therapeutic applications (respiratory disorders, CVD, diabetes, cosmetology, and erectile dysfunction). Glaucoma is a group of eye diseases that affect the optic nerve, which is essential for good vision.

The global HP (high potency) APIs market is segmented -

1) By Type: Innovative HPAPI, Generic HPAPI

2) By Synthesis Type: Synthetic HPAPI, Biotech HPAPI

3) By Therapeutic Application: Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

The global HP (high potency) APIs market size grew from $24.53 billion in 2022 to $26.65 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global high potency APIs is expected to grow from $36.14 billion in 2027 at a CAGR of 7.9%.

The rising number of cancer cases coupled with increasing sales of cancer drugs contributed to the growth of the HP (high potency) APIs market. The rising incidence of cancer is resulting in increasing R&D for anticancer drugs which in turn is propelling the demand for the market. According to the World Health Organization’s International Agency for Research on Cancer (IARC) report, the cancer burden is expected to increase by 29.5 million new cases and 16.4 million deaths by 2040, globally. Moreover, 70% of deaths from cancer occur in middle and low-income countries. Therefore, the growing incidence of cancer cases is projected to upsurge revenues for the HP (high potency) APIs market growth.

Major players in the HP (high potency) APIs market are Eli Lily and Company, Novartis AG, Bristol-Myers Squibb Company, Roche Diagnostics Ltd., Sanofi, Hospira Inc., BASF SE, Covidien PLC., Boehringer Ingelheim GmbH, and Merck & Co. Inc., Sigma Aldrich Corporation, Bayer AG, Carbogen Amcis AG, Lonza, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Mylan Inc., AbbVie, AstraZeneca PLC., and GlaxoSmithKline PLC.

High investment requirements are anticipated to restrain the growth of the HP (high potency) APIs market over the coming years. The HP (high potency) APIs market are cytotoxic, which is harmful to human cells. Moreover, they carry significant handling challenges including the requirement for specialized equipment to avoid cross-contamination, product protection, and ensure environment and operator safety. Additionally, the requirement for appropriate process design and the constant evolution of technologies and industry standards, and specialized containment facilities to facilitate the safety of the employees require huge financial support. Therefore, large investment requirement acts as a major challenge for the growth of the HP (high potency) APIs market.

The companies dealing in the HP (high potency) APIs market are focusing on strategies such as production facility expansion and mergers and acquisitions to maintain their position in the competitive business environment. For instance, in June 2022, MilliporeSigma, a US-based global life science business, opened the doors to its $65 million facility for the production of high-potency active pharmaceutical ingredients (HPAPI), with an emphasis on cancer treatments. In January 2020, Piramal Pharma Solutions (PPS) declared expenditure of $19 million to enhance its operation in Aurora, Ontario, Canada, with an additional 975 m2 of production space in a new wing for API production, including the production of HPAPI for potent compounds down to an OEL of 1 mcg/m3.

In December 2021, SK Capital Partners, a US-based private investment firm, acquired a majority shareholding in SEQENS for an undisclosed amount. Through this acquisition, SEQENS is better positioned as a more potent and concentrated participant in the international markets for specialised ingredients and pharmaceutical solutions. Wavelength Pharmaceuticals, an existing SK Capital portfolio business that is a global manufacturer and developer of active medicinal ingredients, and SEQENS engaged in a combination concurrent with the acquisition. SEQENS is a France-based developer and manufacturer of custom High-Potency APIs.

North America was the largest region in the global HP (high potency) APIs market in 2022. Middle East is expected to be the fastest growing region in the HP (high potency) APIs market report during the forecast period. The regions covered in the HP (high potency) APIs industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the HP (high potency) APIs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The market consists of sales of cytotoxic compounds and sex hormones. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The HP (high potency) APIs market research report is one of a series of new reports from The Business Research Company that provides HP (high potency) APIs market statistics, including HP (high potency) APIs industry global market size, regional shares, competitors with an HP (high potency) APIs market share, detailed HP (high potency) APIs market segments, market trends and opportunities, and any further data you may need to thrive in the HP (high potency) APIs industry. This HP (high potency) APIs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. HP (High Potency) APIs Market Characteristics

    3. HP (High Potency) APIs Market Trends And Strategies

    4. HP (High Potency) APIs Market – Macro Economic Scenario

    4.1 COVID-19 Impact On HP (High Potency) APIs Market

    4.2 Ukraine-Russia War Impact On HP (High Potency) APIs Market

    4.3 Impact Of High Inflation On HP (High Potency) APIs Market

    5. HP (High Potency) APIs Market Size And Growth

    5.1. Global HP (High Potency) APIs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global HP (High Potency) APIs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. HP (High Potency) APIs Market Segmentation

    6.1. Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Innovative HPAPI

    Generic HPAPI

    6.2. Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Synthetic HPAPI

    Biotech HPAPI

    6.3. Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oncology

    Harmonal Disorder

    Glaucoma

    Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

    7. HP (High Potency) APIs Market Regional And Country Analysis

    7.1. Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific HP (High Potency) APIs Market

    8.1. Asia-Pacific HP (High Potency) APIs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China HP (High Potency) APIs Market

    9.1. China HP (High Potency) APIs Market Overview

    9.2. China HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India HP (High Potency) APIs Market

    10.1. India HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan HP (High Potency) APIs Market

    11.1. Japan HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia HP (High Potency) APIs Market

    12.1. Australia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia HP (High Potency) APIs Market

    13.1. Indonesia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea HP (High Potency) APIs Market

    14.1. South Korea HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe HP (High Potency) APIs Market

    15.1. Western Europe HP (High Potency) APIs Market Overview

    15.2. Western Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK HP (High Potency) APIs Market

    16.1. UK HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany HP (High Potency) APIs Market

    17.1. Germany HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France HP (High Potency) APIs Market

    18.3. France HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe HP (High Potency) APIs Market

    19.1. Eastern Europe HP (High Potency) APIs Market Overview

    19.2. Eastern Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia HP (High Potency) APIs Market

    20.1. Russia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America HP (High Potency) APIs Market

    21.1. North America HP (High Potency) APIs Market Overview

    21.2. North America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA HP (High Potency) APIs Market

    22.1. USA HP (High Potency) APIs Market Overview

    22.2. USA HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America HP (High Potency) APIs Market

    23.1. South America HP (High Potency) APIs Market Overview

    23.2. South America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil HP (High Potency) APIs Market

    24.1. Brazil HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East HP (High Potency) APIs Market

    25.1. Middle East HP (High Potency) APIs Market Overview

    25.2. Middle East HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa HP (High Potency) APIs Market

    26.1. Africa HP (High Potency) APIs Market Overview

    26.2. Africa HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. HP (High Potency) APIs Market Competitive Landscape And Company Profiles

    27.1. HP (High Potency) APIs Market Competitive Landscape

    27.2. HP (High Potency) APIs Market Company Profiles

    27.2.1. Eli Lily and Company

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Novartis AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bristol-Myers Squibb Company

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Roche Diagnostics Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Sanofi

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. HP (High Potency) APIs Pipeline Analysis

    29. Key Mergers And Acquisitions In The HP (High Potency) APIs Market

    30. HP (High Potency) APIs Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Eli Lily and Company Financial Performance
  • Table 28: Novartis AG Financial Performance
  • Table 29: Bristol-Myers Squibb Company Financial Performance
  • Table 30: Roche Diagnostics Ltd. Financial Performance
  • Table 31: Sanofi Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Eli Lily and Company Financial Performance
  • Figure 28: Novartis AG Financial Performance
  • Figure 29: Bristol-Myers Squibb Company Financial Performance
  • Figure 30: Roche Diagnostics Ltd. Financial Performance
  • Figure 31: Sanofi Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report